Press Releases

Apr. 23 Sartorius Stedim Biotech : Media Release Q1|2026 PU
Apr. 23 Sartorius Stedim Biotech : Earnings Release Q1|2026 PU
Apr. 23 Sartorius Stedim Biotech : IR Factsheet Q1|2026 PU
Apr. 23 Sartorius Stedim Biotech : Conference Call Q1|2026 Presentation PU
Apr. 23 Sartorius Stedim Biotech reports robust first-quarter results for fiscal 2026 EQ
Mar. 24 Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. EQ
Mar. 17 Sartorius Stedim Biotech : Capital Markets Day 2026 Presentation (ssb capital markets day 2026 data) PU
Mar. 17 Sartorius Stedim Biotech sharpens strategy with biopharma focus and sets new mid-term growth targets EQ
Feb. 16 Sartorius Stedim Biotech : Universal Registration Document 2025 PU
Feb. 16 Sartorius Stedim Biotech : IR Factsheet FY|2025 PU
Feb. 16 Sartorius Stedim Biotech : Conference Call FY|2025 Presentation PU
Feb. 16 Sartorius Stedim Biotech releases Universal Registration Document 2025 EQ
Feb. 16 Sartorius Stedim Biotech SA: Information on Document Availability EQ
Feb. 06 Board of Directors of Sartorius Stedim Biotech S.A. resolves dividend proposal of 0.69 euros EQ
Feb. 03 Sartorius Stedim Biotech achieves considerable profitable growth in 2025 and maintains positive outlook EQ
Jan. 06 Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech EQ
Nov. 03 Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL PU
25-10-16 Sartorius Stedim Biotech : Earnings Release 9M|2025 PU
25-10-16 Sartorius Stedim Biotech : IR Factsheet 9M|2025 PU
25-10-16 Sartorius Stedim Biotech : Conference Call 9M|2025 Presentation PU
25-10-16 Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025 EQ
25-10-06 Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL PU
25-09-02 Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL PU
25-08-12 Sartorius Stedim Biotech and Nanotein Technologies Partner to Advance Cell Therapy Manufacturing AQ
25-08-04 Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL PU
No results for this search